All Type of News
Yuhan & CKD smile in 3rd quarter’s performance among Big 5 pharmas
It was analyzed the Big 5 pharmaceutical companies had different performances in sales in the 3rd quarter.
While Yuhan Corporation and Chong Kun Dang(CKD) recorded decent performances, Hanmi Pharm, Green Cross and Do...
Pushing obligation to report details of medical device distribution
In order to strengthen the observation and management for the medical device distribution, a bill will be prepared to obligate to report details of selling, renting and supplying medical devices.
Assemblyperson Jae-S...
Companies including Daewon and Ahngook challeges to ezetimibe complex market
Korean companies are developing fierce competition in the market of complexes having the more powerful function to inhibit cholesterol than the combination of statin and ezetimibe.
They all are planning to launch th...
Shin Poong announces British NICE’s recommendation on Inisia Tab as primary therapy
Shin Poong Pharm(CEO Jae-Man Yoo) announced the National Institute for Health and Clinical Excellence(NICE), a drug cost-efficacy assessment agency under the British government, recommended the national health insuran...
General inspection on domperidone & Olit’s safety issues
The 20th National Assembly’s Health and Welfare Committee completed its first national inspection. While the general national inspection spent most of its time to determine the truth of the Farmer Nam-Ki Baek’s death,...
Korea on bottom in No. of doctors per 1,000 people among OECD countries
When it comes to the number of doctors, Korea is on the bottom among OECD member countries.
According to the ‘comparison of OECD member countries’ doctors in number’ turned in by the Ministry of Health and Welfare to...
Expansion of Moonlight Children Hospital system, available without pediatrician
Moonlight Children Hospital, which was implemented to resolve pediatric patients’ difficulties of using emergency rooms at night and in holidays, will be drastically expanded.
Due to the expansion of target areas, Mo...
BMS’s Baraclude overcame generic attacks
BMS’s Baraclude, which had continuously lost its position due to the attack of generics, has come back on stabilization.
According to the industry concerned on the 14th, BMS’s Baraclude had successfully led an agreem...
Why did Green Cross change strategy over its hemophilia treatment?
Green Cross changed its target of business to the Chinese market, as suspending the U.S. clinical trial of the hemophilia treatment ‘Greengene F,’ which has been conducted since 2012.
The company was known to judge b...
Among innov. pharmas, Celltrion invested the most into R&D
Among the innovative pharmaceutical companies, Celltrion invested the largest amount into pharmaceutical R&D, and CrystalGenomics recorded the highest R&D/sales investment ratio.
According to the analysis result of t...
